Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Cancer diagnoses and outcomes aren't just about biology — they're about the calendar. A massive study of 30+ million U.S. cancer cases found that January sees the most diagnoses and the worst survival rates, while October — boosted by awareness campaigns — sees earlier-stage diagnoses and better outcomes. Experts say it's a wake-up call for healthcare systems to rethink how they deliver cancer care year-round.
Cancer diagnoses and survival rates shift significantly depending on the time of year, according to a sweeping new analysis published in JAMA Network Open. Researchers examined over 30 million cancer cases across the 10 most common U.S. malignancies from 2001 to 2019 — and found that January is the most challenging month for cancer diagnoses and survival, while October stands out as the strongest.
The December-to-January surge appears driven by a combination of holiday delays, insurance deductible resets, reduced healthcare staffing, and patients deferring symptoms until after the holidays. Meanwhile, October's strong performance — better early-stage diagnoses and survival across multiple cancer types, not just breast cancer — suggests that awareness campaigns genuinely benefit all patients.
By the Numbers:
Why it matters: These findings are a call to action for hospital systems and cancer care teams to audit their own data, boost capacity in October and November, and work to reduce the January surge of late-stage diagnoses — potentially saving lives through smarter scheduling and targeted awareness efforts.